MedTech Firm Doubles Down: $500 Million Fundraise Targets Bitcoin
On April 15, 2025, Semler Scientific (Nasdaq: SMLR), a medical technology company, filed a Form S-3 registration statement with the U.S. Securities and Exchange Commission (SEC) to raise up to $500 million through a mixed-securities offering. The company made clear that the net proceeds would be used primarily to purchase additional bitcoin (BTC), reinforcing its strategy of adopting the cryptocurrency as its primary treasury reserve asset.
Board Chairman Eric Semler commented, "We have reached a settlement in principle, excited to buy more BTC!" This aligns with the company's bitcoin accumulation strategy first adopted in May 2024. Semler Scientific views bitcoin as a long-term store of value, comparable to gold but with greater upside potential due to its fixed supply and rising institutional adoption.
Flexible Financing via Mixed Securities
Under the shelf registration, Semler Scientific may offer debt securities, common stock, preferred stock, warrants, or units in one or more offerings. While proceeds can also be used for general corporate purposes, the primary focus remains bitcoin acquisition. The company has previously deployed capital from senior convertible notes and the sale of a minority equity stake to buy bitcoin, and it also funds purchases through an at-the-market (ATM) equity program and operating cash flow.
As of April 15, 2025, Semler Scientific holds 3,192 bitcoins. At current market prices near $65,000, the portfolio is valued at over $200 million. The company did not specify a timeline for the offering, but market participants expect the fundraising to proceed in tranches over the coming months.
Stock Performance and Market Reaction
Despite bitcoin's wild price swings over the past 12 months—ranging from $50,000 to $109,000—Semler remains steadfast in its bitcoin strategy. On the day of the filing, SMLR shares edged up 0.41%, extending a five-day rally of 8.8%. Analysts note that the company's continued commitment to bitcoin as a treasury asset is being rewarded by investors who see corporate bitcoin holdings as a hedge against inflation and a potential value catalyst.
Semler's approach mirrors that of MicroStrategy, albeit on a smaller scale. The company explicitly addresses risks in its filing, including regulatory changes, digital security vulnerabilities, market liquidity, and the possibility of severe price declines in bitcoin. However, management maintains that these risks do not undermine the long-term rationale of the bitcoin treasury strategy.
Institutional Bitcoin Adoption Broadens
Semler Scientific joins a growing list of publicly traded companies—from MicroStrategy and Tesla to Japan's Metaplanet—that embrace bitcoin as a corporate reserve asset. While Semler's holdings (3,192 BTC) are modest compared to MicroStrategy's 210,000+ BTC, its presence in the medtech sector demonstrates that bitcoin reserve strategies are spreading across industries beyond pure tech and finance.
If the $500 million mixed-securities offering is successfully executed, Semler Scientific could potentially double or triple its bitcoin holdings, depending on future market prices. The market will closely watch the progress of the registration and any subsequent purchases. For bitcoin investors, the news is another bullish signal of sustained corporate demand for the digital asset.